NCT01580826

Brief Summary

We hypothesize that short term infection-related benefits of human milk feeding are decreased by the process of pasteurization. Primary objective of the study is to compare the incidence of late-onset sepsis in very low birth weight infants assigned randomly to receive either pasteurized or raw expressed mothers'own milk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
303

participants targeted

Target at P50-P75 for not_applicable sepsis

Timeline
Completed

Started Mar 2006

Longer than P75 for not_applicable sepsis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2006

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2010

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

April 18, 2012

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 19, 2012

Completed
Last Updated

December 6, 2023

Status Verified

November 1, 2023

Enrollment Period

3.9 years

First QC Date

April 18, 2012

Last Update Submit

November 29, 2023

Conditions

Keywords

pasteurizationhuman milkvery low birth weight infants

Outcome Measures

Primary Outcomes (1)

  • incidence of late-onset sepsis

    the incidence of proven late-onset sepsis, occurring more than 48 hours after birth, with growth of a pathogen or coagulase-negative staphylococci (CoNS) cultured from blood, obtained from a peripheral vein under aseptic conditions, combined with the acute onset of two or more predefined clinical signs and, only in case of growth of a CoNS isolate, at least one laboratory parameter of systemic infection (such as elevated C-reactive protein, left shift or leukopenia).

    up to 8 weeks of age

Secondary Outcomes (1)

  • necrotizing enterocolitis

    up to 8 weeks of age

Study Arms (2)

raw milk

NO INTERVENTION

Infants who were assigned to the raw group received fresh or thawed milk from their own mother, cultured weekly with a semi-quantitative analysis. Raw milk was withheld if it contained any Gram-negative organisms, S. aureus or enterococci.

pasteurized milk

ACTIVE COMPARATOR

Infants who were assigned to pasteurization received own mother's milk heat treated at 62,5°C for 30 minutes with a Sterifeed® S75 TES pasteurizer.

Other: pasteurization of mother's own milk

Interventions

mother's milk heat treated at 62,5°C for 30 minutes with a Sterifeed® S75 TES pasteurizer.

Also known as: pasteurization
pasteurized milk

Eligibility Criteria

Age1 Day - 2 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • all patients born before 32 weeks of gestational age and/or with BW below 1500 g admitted to the tertiary NICU of the University Hospitals Leuven within 24 hours of birth

You may not qualify if:

  • died within 24 hours after birth
  • no consent
  • admitted after 24 hours of birth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals

Leuven, 3000, Belgium

Location

MeSH Terms

Conditions

Sepsis

Interventions

Pasteurization

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Food HandlingFood IndustryIndustryTechnology, Industry, and AgricultureFood PreservationFood Technology

Study Officials

  • Veerle Cossey, Dr

    Universitaire Ziekenhuizen KU Leuven

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prinicpal Investigator

Study Record Dates

First Submitted

April 18, 2012

First Posted

April 19, 2012

Study Start

March 1, 2006

Primary Completion

February 1, 2010

Study Completion

April 1, 2012

Last Updated

December 6, 2023

Record last verified: 2023-11

Locations